277 related articles for article (PubMed ID: 26016443)
1. Interplay between influenza A virus and host factors: targets for antiviral intervention.
Tripathi S; Batra J; Lal SK
Arch Virol; 2015 Aug; 160(8):1877-91. PubMed ID: 26016443
[TBL] [Abstract][Full Text] [Related]
2. 2009 pandemic H1N1 influenza A virus strains display differential pathogenicity in C57BL/6J but not BALB/c mice.
Otte A; Gabriel G
Virulence; 2011; 2(6):563-6. PubMed ID: 22030859
[TBL] [Abstract][Full Text] [Related]
3. 2012-2013 influenza update: hitting a rapidly moving target.
Jin XW; Mossad SB
Cleve Clin J Med; 2012 Nov; 79(11):777-84. PubMed ID: 23125327
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide RNAi screen for viral replication in mammalian cell culture.
Prusty BK; Karlas A; Meyer TF; Rudel T
Methods Mol Biol; 2011; 721():383-95. PubMed ID: 21431699
[TBL] [Abstract][Full Text] [Related]
5. The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.
Liu B; Li NL; Shen Y; Bao X; Fabrizio T; Elbahesh H; Webby RJ; Li K
J Virol; 2016 May; 90(9):4369-4382. PubMed ID: 26889027
[TBL] [Abstract][Full Text] [Related]
6. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
Front Immunol; 2019; 10():60. PubMed ID: 30761132
[TBL] [Abstract][Full Text] [Related]
7. [Swine influenza virus: evolution mechanism and epidemic characterization--a review].
Qi X; Lu C
Wei Sheng Wu Xue Bao; 2009 Sep; 49(9):1138-45. PubMed ID: 20030049
[TBL] [Abstract][Full Text] [Related]
8. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance.
Hu Y; Lu S; Song Z; Wang W; Hao P; Li J; Zhang X; Yen HL; Shi B; Li T; Guan W; Xu L; Liu Y; Wang S; Zhang X; Tian D; Zhu Z; He J; Huang K; Chen H; Zheng L; Li X; Ping J; Kang B; Xi X; Zha L; Li Y; Zhang Z; Peiris M; Yuan Z
Lancet; 2013 Jun; 381(9885):2273-9. PubMed ID: 23726392
[TBL] [Abstract][Full Text] [Related]
9. RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals.
Lesch M; Luckner M; Meyer M; Weege F; Gravenstein I; Raftery M; Sieben C; Martin-Sancho L; Imai-Matsushima A; Welke RW; Frise R; Barclay W; Schönrich G; Herrmann A; Meyer TF; Karlas A
PLoS Pathog; 2019 Mar; 15(3):e1007601. PubMed ID: 30883607
[TBL] [Abstract][Full Text] [Related]
10. Influenza Virus: A Master Tactician in Innate Immune Evasion and Novel Therapeutic Interventions.
Hsu AC
Front Immunol; 2018; 9():743. PubMed ID: 29755452
[TBL] [Abstract][Full Text] [Related]
11. H5N1 Avian influenza: preventive and therapeutic strategies against a pandemic.
Sambhara S; Poland GA
Annu Rev Med; 2010; 61():187-98. PubMed ID: 20059335
[TBL] [Abstract][Full Text] [Related]
12. Role for proteases and HLA-G in the pathogenicity of influenza A viruses.
Foucault ML; Moules V; Rosa-Calatrava M; Riteau B
J Clin Virol; 2011 Jul; 51(3):155-9. PubMed ID: 21612979
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a fully human monoclonal antibody against multiple influenza A viral strains in mice and a pandemic H1N1 strain in nonhuman primates.
Song A; Myojo K; Laudenslager J; Harada D; Miura T; Suzuki K; Kuni-Kamochi R; Soloff R; Ohgami K; Kanda Y
Antiviral Res; 2014 Nov; 111():60-8. PubMed ID: 25218949
[TBL] [Abstract][Full Text] [Related]
14. Novel human H7N9 influenza virus in China.
Wang C; Luo J; Wang J; Su W; Gao S; Zhang M; Xie L; Ding H; Liu S; Liu X; Chen Y; Jia Y; He H
Integr Zool; 2014 Jun; 9(3):372-5. PubMed ID: 24952971
[TBL] [Abstract][Full Text] [Related]
15. A(H7N9) virus results in early induction of proinflammatory cytokine responses in both human lung epithelial and endothelial cells and shows increased human adaptation compared with avian H5N1 virus.
Zeng H; Belser JA; Goldsmith CS; Gustin KM; Veguilla V; Katz JM; Tumpey TM
J Virol; 2015 Apr; 89(8):4655-67. PubMed ID: 25673714
[TBL] [Abstract][Full Text] [Related]
16. The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus.
Haasbach E; Reiling SJ; Ehrhardt C; Droebner K; Rückle A; Hrincius ER; Leban J; Strobl S; Vitt D; Ludwig S; Planz O
Antiviral Res; 2013 Sep; 99(3):336-44. PubMed ID: 23811282
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Influenza A Virus Sequence Pairs and Their Combinations for Simultaneous Heterosubtypic Targeting that Hedge against Antiviral Resistance.
Wee KB; Lee RT; Lin J; Pramono ZA; Maurer-Stroh S
PLoS Comput Biol; 2016 Jan; 12(1):e1004663. PubMed ID: 26771381
[TBL] [Abstract][Full Text] [Related]
18. A small molecule multi-kinase inhibitor reduces influenza A virus replication by restricting viral RNA synthesis.
Martinez-Gil L; Alamares-Sapuay JG; Ramana Reddy MV; Goff PH; Premkumar Reddy E; Palese P
Antiviral Res; 2013 Oct; 100(1):29-37. PubMed ID: 23891991
[TBL] [Abstract][Full Text] [Related]
19. Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis.
Shim JM; Kim J; Tenson T; Min JY; Kainov DE
Viruses; 2017 Aug; 9(8):. PubMed ID: 28805681
[TBL] [Abstract][Full Text] [Related]
20. Web of interferon stimulated antiviral factors to control the influenza A viruses replication.
Goraya MU; Zaighum F; Sajjad N; Anjum FR; Sakhawat I; Rahman SU
Microb Pathog; 2020 Feb; 139():103919. PubMed ID: 31830579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
